[
  {
    "objectID": "quarto/index.html",
    "href": "quarto/index.html",
    "title": "Impact of Hypoglycemia on 30-Day Readmission and Survival Outcomes in Patients with Type 2 Diabetes Mellitus",
    "section": "",
    "text": "Study Objective:\nTo identify patient- and hospital-level predictors of 30-day all-cause hospital readmission among adults hospitalized with T2DM using a nationally representative dataset. This study also evaluates the clinical and economic burden of readmission in this high-risk population, including its associations with in-hospital mortality, length of stay (LOS), and hospital charges.\nData Source:\nA retrospective cohort study using the 2016–2017 Nationwide Readmissions Database (NRD), developed by the Healthcare Cost and Utilization Project (HCUP). The NRD enables tracking of individual patients across hospitalizations within a given year via synthetic identifiers, capturing discharges from U.S. community hospitals and supporting survey-weighted national estimates through complex sampling design.\nCohort Definition:\nIndex hospitalizations were included if they met all of the following criteria:\n\nAdults aged ≥18 years\nPrincipal diagnosis of T2DM, with or without hypoglycemia, identified using ICD-10-CM code: E1164\nNon-elective admission\nIndex discharge by the end of November to allow for a complete 30-day follow-up period\nComplete data on LOS and NRD_DAYSTOEVENT, required to compute discharge dates\n\nOutcomes of Interest:\n\nPrimary Outcome:\n\nAll-cause 30-day readmission (Yes/No), flagged using NRD linkage variables\n\nSecondary Outcomes (index admission):\n\nIn-hospital mortality (DIED)\nLength of stay (LOS, in days)\nTotal hospitalization charges (TOTCHG), inflation-adjusted to 2017 USD\nNon-home discharge\n\nReadmission Characteristics:\n\nIn-hospital mortality\nLength of stay (LOS, in days)\nTotal hospitalization charges (inflation-adjusted to 2017 USD)\n\n\nOutcome Definitions:\n\nReadmission:\n\nDefined using HCUP NRD’s methodology. Readmissions were identified only among patients with qualifying index events.\nTrauma-related hospitalizations were excluded only from the readmission pool to avoid unrelated admissions.\n\nMortality:\n\nIn-hospital death recorded during index or readmission (DIED = 1)\n\nLOS:\n\nReported in days; modeled as count outcome\n\nCharge:\n\nDerived from HCUP’s TOTCHG variable and adjusted to 2017 dollars using Consumer Price Index (CPI) data\n\nNon-Home Discharge:\n\nDefined as any disposition other than home/self-care, specifically:\n\nTransfer to another short-term hospital\nTransfer to skilled nursing facility (SNF), intermediate, or other facility\nLeft against medical advice\nDied in hospital\nAlive, destination unknown\n\n\n\nCovariates and Variable Construction:\n\nDemographic & Socioeconomic Factors:\n\nAge (continuous)\nSex (FEMALE; ref = Male)\nPrimary expected payer (Insurance; Medicare, Medicaid, Private, Other)\nIncome quartile based on ZIP code (ZIPINC_QRTL)\nWeekend admission (AWEEKEND)\n\nComorbidities and Clinical Covariates: (from Elixhauser and Charlson flags)\n\nCongestive heart failure\nHypertension\nRenal failure\nLiver disease\nPeripheral vascular disease\nChronic pulmonary disease\nDementia\nFluid and electrolyte imbalance\n\nHospital Characteristics:\n\nHospital bed size (Small, Medium, Large)\nUrban/rural teaching status (Metropolitan, teaching vs non-teaching, etc.)\n\nDisposition and Severity:\n\nNon-home discharge (e.g., SNF, hospice, other facilities, or death)\nLength of stay\n\n\nStatistical Methods:\n\nSurvey Design and Weighting:\n\nAll analyses accounted for NRD’s complex survey design using weights (DISCWT), strata (NRD_STRATUM), and clustering (HOSP_NRD). Survey-adjusted methods were implemented via survey and srvyr packages.\n\nDescriptive Analyses:\n\nBaseline characteristics were summarized across T2DM without hypoglcemia vs.T2DM with hypoglycemia groups using survey-weighted means/proportions.\nP-values from design-based statistical tests (Rao–Scott adjusted chi-square for categorical variables; design-based Kruskal–Wallis test for continuous variables).\n\nMultivariable Regression:\n\nThe model included demographic, clinical, hospital-level, and index-stay factors.\nHazard ratios (HRs) with 95% confidence intervals (CIs) were reported\n\nReadmission Characteristics:\n\nA sub-analysis among patients with 30-day readmissions summarized readmission hospitalization characteristics descriptively using weighted survey statistics.\n\n\nSoftware: All analyses were conducted in R Statistical Language (Version 4.5.0; R Foundation for Statistical Computing, Vienna, Austria)."
  },
  {
    "objectID": "quarto/index.html#preamble",
    "href": "quarto/index.html#preamble",
    "title": "Impact of Hypoglycemia on 30-Day Readmission and Survival Outcomes in Patients with Type 2 Diabetes Mellitus",
    "section": "",
    "text": "Study Objective:\nTo identify patient- and hospital-level predictors of 30-day all-cause hospital readmission among adults hospitalized with T2DM using a nationally representative dataset. This study also evaluates the clinical and economic burden of readmission in this high-risk population, including its associations with in-hospital mortality, length of stay (LOS), and hospital charges.\nData Source:\nA retrospective cohort study using the 2016–2017 Nationwide Readmissions Database (NRD), developed by the Healthcare Cost and Utilization Project (HCUP). The NRD enables tracking of individual patients across hospitalizations within a given year via synthetic identifiers, capturing discharges from U.S. community hospitals and supporting survey-weighted national estimates through complex sampling design.\nCohort Definition:\nIndex hospitalizations were included if they met all of the following criteria:\n\nAdults aged ≥18 years\nPrincipal diagnosis of T2DM, with or without hypoglycemia, identified using ICD-10-CM code: E1164\nNon-elective admission\nIndex discharge by the end of November to allow for a complete 30-day follow-up period\nComplete data on LOS and NRD_DAYSTOEVENT, required to compute discharge dates\n\nOutcomes of Interest:\n\nPrimary Outcome:\n\nAll-cause 30-day readmission (Yes/No), flagged using NRD linkage variables\n\nSecondary Outcomes (index admission):\n\nIn-hospital mortality (DIED)\nLength of stay (LOS, in days)\nTotal hospitalization charges (TOTCHG), inflation-adjusted to 2017 USD\nNon-home discharge\n\nReadmission Characteristics:\n\nIn-hospital mortality\nLength of stay (LOS, in days)\nTotal hospitalization charges (inflation-adjusted to 2017 USD)\n\n\nOutcome Definitions:\n\nReadmission:\n\nDefined using HCUP NRD’s methodology. Readmissions were identified only among patients with qualifying index events.\nTrauma-related hospitalizations were excluded only from the readmission pool to avoid unrelated admissions.\n\nMortality:\n\nIn-hospital death recorded during index or readmission (DIED = 1)\n\nLOS:\n\nReported in days; modeled as count outcome\n\nCharge:\n\nDerived from HCUP’s TOTCHG variable and adjusted to 2017 dollars using Consumer Price Index (CPI) data\n\nNon-Home Discharge:\n\nDefined as any disposition other than home/self-care, specifically:\n\nTransfer to another short-term hospital\nTransfer to skilled nursing facility (SNF), intermediate, or other facility\nLeft against medical advice\nDied in hospital\nAlive, destination unknown\n\n\n\nCovariates and Variable Construction:\n\nDemographic & Socioeconomic Factors:\n\nAge (continuous)\nSex (FEMALE; ref = Male)\nPrimary expected payer (Insurance; Medicare, Medicaid, Private, Other)\nIncome quartile based on ZIP code (ZIPINC_QRTL)\nWeekend admission (AWEEKEND)\n\nComorbidities and Clinical Covariates: (from Elixhauser and Charlson flags)\n\nCongestive heart failure\nHypertension\nRenal failure\nLiver disease\nPeripheral vascular disease\nChronic pulmonary disease\nDementia\nFluid and electrolyte imbalance\n\nHospital Characteristics:\n\nHospital bed size (Small, Medium, Large)\nUrban/rural teaching status (Metropolitan, teaching vs non-teaching, etc.)\n\nDisposition and Severity:\n\nNon-home discharge (e.g., SNF, hospice, other facilities, or death)\nLength of stay\n\n\nStatistical Methods:\n\nSurvey Design and Weighting:\n\nAll analyses accounted for NRD’s complex survey design using weights (DISCWT), strata (NRD_STRATUM), and clustering (HOSP_NRD). Survey-adjusted methods were implemented via survey and srvyr packages.\n\nDescriptive Analyses:\n\nBaseline characteristics were summarized across T2DM without hypoglcemia vs.T2DM with hypoglycemia groups using survey-weighted means/proportions.\nP-values from design-based statistical tests (Rao–Scott adjusted chi-square for categorical variables; design-based Kruskal–Wallis test for continuous variables).\n\nMultivariable Regression:\n\nThe model included demographic, clinical, hospital-level, and index-stay factors.\nHazard ratios (HRs) with 95% confidence intervals (CIs) were reported\n\nReadmission Characteristics:\n\nA sub-analysis among patients with 30-day readmissions summarized readmission hospitalization characteristics descriptively using weighted survey statistics.\n\n\nSoftware: All analyses were conducted in R Statistical Language (Version 4.5.0; R Foundation for Statistical Computing, Vienna, Austria)."
  },
  {
    "objectID": "quarto/index.html#descriptive-analyses",
    "href": "quarto/index.html#descriptive-analyses",
    "title": "Impact of Hypoglycemia on 30-Day Readmission and Survival Outcomes in Patients with Type 2 Diabetes Mellitus",
    "section": "Descriptive Analyses",
    "text": "Descriptive Analyses\n\nBaseline Characteristics\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\nCharacteristic\nOverall\nN = 584,3571\nT2DM with hypoglycemia\nN = 81,2861\nT2DM without hypoglycemia\nN = 503,0711\np-value2\n\n\n\n\nAge (years)\n\n\n\n\n\n\n&lt;0.001\n\n\n    18–49\n124,338 (21%)\n5,471 (6.7%)\n118,867 (24%)\n\n\n\n\n    50–64\n226,128 (39%)\n20,571 (25%)\n205,558 (41%)\n\n\n\n\n    65–79\n168,418 (29%)\n34,323 (42%)\n134,095 (27%)\n\n\n\n\n    80+\n65,473 (11%)\n20,921 (26%)\n44,551 (8.9%)\n\n\n\n\nSex\n\n\n\n\n\n\n&lt;0.001\n\n\n    Male\n340,969 (58%)\n38,769 (48%)\n302,199 (60%)\n\n\n\n\n    Female\n243,388 (42%)\n42,517 (52%)\n200,872 (40%)\n\n\n\n\nMedian Income Quartile\n\n\n\n\n\n\n&lt;0.001\n\n\n    0-25th percentile\n228,855 (40%)\n30,819 (38%)\n198,036 (40%)\n\n\n\n\n    26th to 50th percentile\n154,495 (27%)\n20,854 (26%)\n133,641 (27%)\n\n\n\n\n    51st to 75th percentile\n118,105 (21%)\n17,012 (21%)\n101,093 (20%)\n\n\n\n\n    76th to 100th percentile\n74,439 (13%)\n11,603 (14%)\n62,836 (13%)\n\n\n\n\nHospital Bed Size\n\n\n\n\n\n\n0.003\n\n\n    Small\n96,554 (17%)\n13,815 (17%)\n82,739 (16%)\n\n\n\n\n    Large\n318,246 (54%)\n43,126 (53%)\n275,121 (55%)\n\n\n\n\n    Medium\n169,556 (29%)\n24,345 (30%)\n145,212 (29%)\n\n\n\n\nHospital Teaching Status\n\n\n\n\n\n\n&lt;0.001\n\n\n    Metropolitan, non-teaching\n149,745 (26%)\n22,379 (28%)\n127,366 (25%)\n\n\n\n\n    Metropolitan, teaching\n380,562 (65%)\n51,081 (63%)\n329,481 (65%)\n\n\n\n\n    Non-metropolitan\n54,049 (9.2%)\n7,826 (9.6%)\n46,224 (9.2%)\n\n\n\n\nInsurance\n\n\n\n\n\n\n&lt;0.001\n\n\n    Private\n101,527 (17%)\n7,354 (9.1%)\n94,173 (19%)\n\n\n\n\n    Medicaid\n110,215 (19%)\n8,826 (11%)\n101,389 (20%)\n\n\n\n\n    Other\n371,746 (64%)\n65,021 (80%)\n306,725 (61%)\n\n\n\n\nDischarged to Non-Home Setting\n135,690 (23%)\n22,712 (28%)\n112,978 (22%)\n&lt;0.001\n\n\nNo. of comorbidities\n\n\n\n\n\n\n&lt;0.001\n\n\n    One comorbidity\n95,941 (16%)\n12,501 (15%)\n83,439 (17%)\n\n\n\n\n    Two or more comorbidities\n488,416 (84%)\n68,785 (85%)\n419,632 (83%)\n\n\n\n\nCongestive heart failure\n127,508 (22%)\n24,842 (31%)\n102,666 (20%)\n&lt;0.001\n\n\nLiver disease\n30,014 (5.1%)\n4,455 (5.5%)\n25,559 (5.1%)\n0.002\n\n\nObesity\n142,684 (24%)\n13,956 (17%)\n128,727 (26%)\n&lt;0.001\n\n\nHypertension\n475,988 (81%)\n70,372 (87%)\n405,616 (81%)\n&lt;0.001\n\n\nRenal disease\n221,883 (38%)\n39,222 (48%)\n182,661 (36%)\n&lt;0.001\n\n\nPeripheral vascular disease\n92,682 (16%)\n8,783 (11%)\n83,900 (17%)\n&lt;0.001\n\n\nDepression\n87,222 (15%)\n12,038 (15%)\n75,184 (15%)\n0.6\n\n\nChronic pulmonary disease\n107,366 (18%)\n18,927 (23%)\n88,438 (18%)\n&lt;0.001\n\n\nDementia\n40,184 (6.9%)\n12,780 (16%)\n27,404 (5.4%)\n&lt;0.001\n\n\nFluid and electrolyte imbalance\n248,530 (43%)\n33,493 (41%)\n215,036 (43%)\n&lt;0.001\n\n\n\n1 n (%)\n\n\n2 Pearson’s X^2: Rao & Scott adjustment\n\n\n\n\n\n\n\n\n\n\nOutcomes of Index Hospitalizations\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\nCharacteristic\nOverall\nN = 584,3571\nT2DM with hypoglycemia\nN = 81,2861\nT2DM without hypoglycemia\nN = 503,0711\np-value2\n\n\n\n\n30-Day Readmission\n\n\n\n\n\n\n&lt;0.001\n\n\n    Without Readmission\n501,653 (86%)\n69,271 (85%)\n432,383 (86%)\n\n\n\n\n    With 30-day readmission\n82,704 (14%)\n12,015 (15%)\n70,689 (14%)\n\n\n\n\nIn-Hospital Mortality\n4,534 (0.8%)\n1,193 (1.5%)\n3,341 (0.7%)\n&lt;0.001\n\n\nLength of Stay (days)\n4.0 (2.0, 7.0)\n3.0 (2.0, 4.0)\n4.0 (2.0, 7.0)\n&lt;0.001\n\n\nInflation-Adjusted Total Charges ($)\n29,983 (16,168, 58,778)\n22,020 (13,207, 38,272)\n31,820 (16,877, 62,864)\n&lt;0.001\n\n\nDischarged to Non-Home Setting\n135,690 (23%)\n22,712 (28%)\n112,978 (22%)\n&lt;0.001\n\n\n\n1 n (%); Median (Q1, Q3)\n\n\n2 Pearson’s X^2: Rao & Scott adjustment; Design-based KruskalWallis test"
  },
  {
    "objectID": "quarto/index.html#readmission-hospitalization-characteristics",
    "href": "quarto/index.html#readmission-hospitalization-characteristics",
    "title": "Impact of Hypoglycemia on 30-Day Readmission and Survival Outcomes in Patients with Type 2 Diabetes Mellitus",
    "section": "Readmission Hospitalization Characteristics",
    "text": "Readmission Hospitalization Characteristics\n\nReadmission Rate:\nIndex hospitalizations resulted in:\n\nReadmission (n): 82703\nReadmission Rate (%): 14.15%\nReadmission Rate (95% CI): 13.97% to 14.33%\n\n\n\nIn-Hospital Mortality by Readmission Status:\n\n\nIn-Hospital Mortality Among Readmitted Patients\nReadmission hospitalizations resulted in:\n\nDeaths (n): 2555\nDeath Rate (%): 3.1%\nDeath Rate (95% CI): 2.92% to 3.28%\n\n\n\nResource Utilization During Readmission\nReadmission hospitalizations resulted in:\n\nMedian Length of Stay (IQR), days: 4 (IQR: 2–7)\nMedian Total Charges (IQR): $33,580 (IQR: $18,435–$64,261)"
  },
  {
    "objectID": "quarto/index.html#multivariable-analyses",
    "href": "quarto/index.html#multivariable-analyses",
    "title": "Impact of Hypoglycemia on 30-Day Readmission and Survival Outcomes in Patients with Type 2 Diabetes Mellitus",
    "section": "Multivariable Analyses",
    "text": "Multivariable Analyses\n\n30-Day Readmission:\n\n\n\n\n\n\n\n\n\n\n\n\n\n\nCharacteristic\nOR\n95% CI\np-value\n\n\n\n\nHypoglycemia categories\n\n\n\n\n\n\n\n\n    T2DM with hypoglycemia\n—\n—\n\n\n\n\n    T2DM without hypoglycemia\n0.94\n0.91, 0.97\n&lt;0.001\n\n\nAge (years)\n0.99\n0.99, 0.99\n&lt;0.001\n\n\nSex\n\n\n\n\n\n\n\n\n    Male\n—\n—\n\n\n\n\n    Female\n1.20\n1.17, 1.24\n&lt;0.001\n\n\nInsurance\n\n\n\n\n\n\n\n\n    Private\n—\n—\n\n\n\n\n    Medicaid\n1.54\n1.46, 1.61\n&lt;0.001\n\n\n    Other\n1.46\n1.40, 1.51\n&lt;0.001\n\n\nMedian Income Quartile\n\n\n\n\n\n\n\n\n    0-25th percentile\n—\n—\n\n\n\n\n    26th to 50th percentile\n0.93\n0.91, 0.96\n&lt;0.001\n\n\n    51st to 75th percentile\n0.90\n0.87, 0.94\n&lt;0.001\n\n\n    76th to 100th percentile\n0.88\n0.84, 0.92\n&lt;0.001\n\n\nHospital Bed Size\n\n\n\n\n\n\n\n\n    Small\n—\n—\n\n\n\n\n    Large\n1.02\n0.98, 1.06\n0.3\n\n\n    Medium\n1.02\n0.98, 1.07\n0.4\n\n\nHospital Teaching Status\n\n\n\n\n\n\n\n\n    Metropolitan, non-teaching\n—\n—\n\n\n\n\n    Metropolitan, teaching\n0.96\n0.93, 0.99\n0.019\n\n\n    Non-metropolitan\n0.91\n0.86, 0.97\n0.002\n\n\nDischarged to Non-Home Setting\n\n\n\n\n\n\n\n\n    No\n—\n—\n\n\n\n\n    Yes\n1.11\n1.08, 1.14\n&lt;0.001\n\n\nNo. of comorbidities\n\n\n\n\n\n\n\n\n    One comorbidity\n—\n—\n\n\n\n\n    Two or more comorbidities\n1.68\n1.61, 1.75\n&lt;0.001\n\n\nCongestive heart failure\n\n\n\n\n\n\n\n\n    No\n—\n—\n\n\n\n\n    Yes\n1.34\n1.30, 1.37\n&lt;0.001\n\n\nChronic pulmonary disease\n\n\n\n\n\n\n\n\n    No\n—\n—\n\n\n\n\n    Yes\n1.08\n1.05, 1.11\n&lt;0.001\n\n\nObesity\n\n\n\n\n\n\n\n\n    No\n—\n—\n\n\n\n\n    Yes\n0.79\n0.76, 0.81\n&lt;0.001\n\n\nLiver disease\n\n\n\n\n\n\n\n\n    No\n—\n—\n\n\n\n\n    Yes\n1.11\n1.06, 1.17\n&lt;0.001\n\n\nHypertension\n\n\n\n\n\n\n\n\n    No\n—\n—\n\n\n\n\n    Yes\n1.05\n1.01, 1.08\n0.008\n\n\nRenal disease\n\n\n\n\n\n\n\n\n    No\n—\n—\n\n\n\n\n    Yes\n1.28\n1.25, 1.31\n&lt;0.001\n\n\nPeripheral vascular disease\n\n\n\n\n\n\n\n\n    No\n—\n—\n\n\n\n\n    Yes\n1.09\n1.05, 1.12\n&lt;0.001\n\n\nDepression\n\n\n\n\n\n\n\n\n    No\n—\n—\n\n\n\n\n    Yes\n1.11\n1.08, 1.15\n&lt;0.001\n\n\nDementia\n\n\n\n\n\n\n\n\n    No\n—\n—\n\n\n\n\n    Yes\n1.00\n0.95, 1.05\n&gt;0.9\n\n\nFluid and electrolyte imbalance\n\n\n\n\n\n\n\n\n    No\n—\n—\n\n\n\n\n    Yes\n1.11\n1.08, 1.13\n&lt;0.001\n\n\nDrug_abuse\n\n\n\n\n\n\n\n\n    No\n—\n—\n\n\n\n\n    Yes\n1.39\n1.32, 1.46\n&lt;0.001\n\n\n\nAbbreviations: CI = Confidence Interval, OR = Odds Ratio"
  }
]